Replies to post #21135 on OncoSec Medical Inc (ONCSQ)

[furbush87]

I didn't start following PVCT until they had already surged over $6. I found it surprising that they were that high with just a P2 Melanoma trial and data that IMO was only slightly better than ONCS. Of course that is so subjective because with P2 its all about endpoints and company long term goals.
I believe ONCS has the capacity to get that high as well, but I think to sustain that price you have to actually have data and not hype.